Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 20.1.2020 | EN | Official Journal of the European Union | C 19/47 |

---

Judgment of the General Court of 20 November 2019 — Werner v EUIPO — Merck (fLORAMED)

(Case T-695/18) [(1)](#ntr1-C_2020019EN.01004701-E0001)

(EU trade mark - Opposition proceedings - Application for the EU figurative mark fLORAMED - Earlier EU word mark MEDIFLOR - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)

(2020/C 19/56)

Language of the case: German

Parties

Applicant: Stefan Werner (Baldham, Germany) (represented by: T Büttner, lawyer)

Defendant: European Union Intellectual Property Office (represented by: S. Hanne, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Merck KGaA (Darmstadt, Germany) (represented by: U. Pfleghar, M. Best, M. Giannakoulis and S. Schäffner, lawyers)

Re:

Action brought against the decision of the Second Board of Appeal of EUIPO of 17 September 2018 (Case R 197/2018-2), relating to opposition proceedings between Merck and Mr Werner.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | dismisses the action; |

|  |  |
| --- | --- |
| 2. | orders Mr Stefan Werner to pay the costs. |

---

---

[Top](#document1)